Home/Filings/4/0001062993-23-001490
4//SEC Filing

STUART LEWIS J 4

Accession 0001062993-23-001490

CIK 0001042074other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:26 PM ET

Size

5.3 KB

Accession

0001062993-23-001490

Insider Transaction Report

Form 4
Period: 2023-01-25
STUART LEWIS J
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-01-25+215,000215,000 total
    Exercise: $7.80Exp: 2033-01-24Common Stock (215,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/48 of the underlying shares monthly from January 1, 2023.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001407368

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:26 PM ET
Size
5.3 KB